| Date Filed | Type | Description |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $11.22, valued at
$2.8k
|
|
| 03/16/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $12.71, valued at
$3.2k
|
|
| 02/28/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $15.395, valued at
$3.8k
|
|
| 02/07/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $20.84, valued at
$5.2k
|
|
| 01/30/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $19.2, valued at
$4.8k
|
|
| 01/17/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $16.5, valued at
$4.1k
|
|
| 12/20/2022 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $12.94, valued at
$3.2k
|
|
| 12/06/2022 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $13.98, valued at
$3.5k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 500 shares
@ $16.74, valued at
$8.4k
|
|
| 02/01/2022 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 500 shares
@ $18.47, valued at
$9.2k
|
|
| 01/24/2022 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 500 shares
@ $16.33, valued at
$8.2k
|
|
| 01/19/2022 |
4
| Thompson Jaye (VP Clinical Reg. Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 500 shares
@ $18.87, valued at
$9.4k
|
|
| 01/14/2022 |
4
| Thompson Jaye (VP Clinical Reg. Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $19.99, valued at
$20k
|
|
| 01/11/2022 |
3
| Thompson Jaye (VP Clinical & Reg. Affairs) has filed a Form 3 on Greenwich LifeSciences, Inc. |
| 09/30/2020 |
3/A
| Thompson Jaye (VP Clinical & Reg Affairs) has filed a Form 3/A on Greenwich LifeSciences, Inc. |
| 09/24/2020 |
3
| Thompson Jaye (VPC AND REGULATORY AFFAIRS) has filed a Form 3 on Greenwich LifeSciences, Inc. |
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2013 |
4
| Thompson Jaye (SVP Clinical Dev & Reg Affairs) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 10,469 options to buy
@ $0 |
|
| 06/14/2012 |
4
| Thompson Jaye (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.|
Txns:
| Granted 5,000 options
@ $7.88, valued at
$39.4k
|
|
| 01/10/2012 |
4
| Thompson Jaye (SVP of Clin Dev & Reg Affairs) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 38,388 options to buy
@ $0.95, valued at
$36.5k
|
|
| 06/03/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2011 |
4
| Thompson Jaye (SVP of Clin Dev & Reg Affairs) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.56, valued at
$39k
|
|
| 05/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2009 |
4
| Thompson Jaye (Sr VP Clin Dev & Reg Affairs) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.05, valued at
$102.5k
|
|
| 11/30/2009 |
3
| Thompson Jaye (Sr VP Clin Dev & Reg Affairs) has filed a Form 3 on Opexa Therapeutics, Inc. |
| 11/20/2009 |
4
| Thompson Jaye (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7, valued at
$28k
|
|
| 11/20/2009 |
3
| Form 3 - Initial statement of beneficial ownership of securities |